Acura Pharmaceuticals, Inc. (ACUR)

New Form 8-K - ACURA PHARMACEUTICALS, INC Filed: 2025-09-04 AccNo: 0001104659-25-087312 Size: 236 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits